News
Harvard Researchers Develop AI-Driven Framework To Study Social Interactions, A Step Forward for Autism Research
News
Harvard Innovation Labs Announces 25 President’s Innovation Challenge Finalists
News
Graduate Student Council To Vote on Meeting Attendance Policy
News
Pop Hits and Politics: At Yardfest, Students Dance to Bedingfield and a Student Band Condemns Trump
News
Billionaire Investor Gerald Chan Under Scrutiny for Neglect of Historic Harvard Square Theater
Dr. Edwin J. Cohn, Higgins University Professor, yesterday announced a new blood medicine that may replace plasma is some cases.
Cohn and a group of doctors told the National Academy of Sciences that this medicine, which is derived from the human blood, may be used to combat shock and treat burns. The scientists expect it will replace both plasma and serum albumin, an anti-shock medicine, in use against war wounds or atom-bomb casualties.
The medicine is called Stable Plasma Protein Solution, and is produced automatically by a machine. Blood does not flow into a bottle, but directly from donor to machine.
Here it is broken down by chemicals and sugars. The machine extracts and packages over half a dozen medicines from the blood, which may be used to fight measles and other diseases. With this instrument, outdated blood can be used even after the present safety limit of three weeks.
Want to keep up with breaking news? Subscribe to our email newsletter.